Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Administrative Updates topic
No spam. Unsubscribe anytime.
Board approves multiple FAQs, self‑assessment forms and takes positions on pharmacy legislation
Summary
The board approved updated FAQs on medication error reporting and automated drug delivery systems, adopted several revised self‑assessment forms, accepted enforcement and licensing statistics, and voted to take recommended positions on a package of bills including PBM transparency measures.
At its April 30 meeting in Sacramento, the California State Board of Pharmacy approved a series of administrative updates and legislative recommendations intended to help implement recent statutory changes and streamline oversight.
Action on FAQs and forms: The board approved updated Frequently Asked Questions on medication error reporting and on automated drug delivery systems and delegated to the board chair (and the president) authority to finalize technical, non‑substantive formatting edits to the FAQ documents for web publication. Members also approved updated self‑assessment forms for wholesaler third‑party logistics providers, surgical clinics and hospitals, noting corrected links and nomenclature changes and asking staff to ensure links match the referenced regulations.
Enforcement and licensing statistics: Chair Maria Serpa summarized enforcement activity through the fiscal year, noting the board initiated 2,863 complaints and closed 2,185 investigations with 2,136 field investigations pending as of April 1, 2026. Licensing staff reported nearly 7,000 individual licenses and several hundred site licenses issued in the fiscal year to date and flagged increased technician application volumes; members thanked staff for processing work and noted continued attention to application turnaround times.
Nonresident pharmacy policy: The board amended and approved a policy statement to implement AB 1503 changes for nonresident pharmacies, inserting language that the board does not intend to proactively restrict or interrupt otherwise lawful pharmacy services during the transition to a new pharmacist‑in‑charge (PIC) California‑licensure requirement; the board will consider good‑faith efforts to comply in enforcement assessments.
Legislative positions: The legislation committee recommended and the board recorded support positions for several bills that the staff and committee judged aligned with board policy, including measures to strengthen PBM transparency and data reporting pathways (committee items such as AB 910 and AB 1773) and other matters identified in the meeting materials; some bills were recommended for monitoring rather than a formal position.
Votes and next steps: Most administrative motions carried on roll calls, typically unanimously among members present. Staff will post the updated materials and distribute subscriber alerts to the regulated community; committees will continue follow‑up where further refinement is needed.
End note: Where statutes or regulations were discussed, the board generally directed staff to prepare clarifying FAQs and to pursue rulemaking only when interpretive or location issues could not be solved by guidance.
